Ultragenyx Pharmaceutical
RARE
RARE
158 hedge funds and large institutions have $3.75B invested in Ultragenyx Pharmaceutical in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 165 → 158 (-7)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
Holders
158
Holding in Top 10
–
Calls
$13.2M
Puts
$14.2M
Top Buyers
| 1 | +$41.9M | |
| 2 | +$37.8M | |
| 3 | +$31.5M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$31.4M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$24.7M |
Top Sellers
| 1 | -$37.4M | |
| 2 | -$33.7M | |
| 3 | -$28.3M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$22.7M |
| 5 |
Goldman Sachs
New York
|
-$21.9M |